Birch triterpenes by Chiesi Farmaceutici for Radiodermatitis: Likelihood of Approval

Birch triterpenes is under clinical development by Chiesi Farmaceutici and currently in Phase II for Radiodermatitis.

California Passes Law Enabling MDMA And Psilocybin Prescriptions When Federally Legal

Gavin Newsom made a bold maneuver in the realm of psychedelic medicine recently. The Democrat Governor signed a groundbreaking law authorizing medical prescriptions for substances

October 5, 2023

Building Cybersecurity Resilience in American Rural Hospitals

Mike Hamilton, Founder and CISO of Critical Insight To stop ransomware terrorists from locking up our Nation’s hospitals, the Federal Government is pushing patient-focused entities

August 9, 2023

What would a second Trump presidency look like for health care?

On the presidential campaign trail, former President Donald Trump is, once again, promising to repeal and replace the Affordable Care Act — a nebulous goal

January 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.